Brian DeSchuytner
Finanzdirektor/CFO bei MERSANA THERAPEUTICS, INC.
Vermögen: 127 011 $ am 31.05.2024
Aktive Positionen von Brian DeSchuytner
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MERSANA THERAPEUTICS, INC. | Geschäftsführer | 06.09.2023 | - |
| Finanzdirektor/CFO | 10.07.2019 | - |
Karriereverlauf von Brian DeSchuytner
Ehemalige bekannte Positionen von Brian DeSchuytner
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TESARO INC | Corporate Officer/Principal | 01.01.2017 | 01.06.2019 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2009 | 01.01.2017 |
Ausbildung von Brian DeSchuytner
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Dartmouth College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Director of Finance/CFO | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MERSANA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Brian DeSchuytner
- Erfahrung
